A Catalog of the Pathogenic Mutations of LDL Receptor Gene in Japanese Familial Hypercholesterolemia
Affiliations
- PMID: 32331935
- DOI: 10.1016/j.jacl.2020.03.002
Abstract
Background: Little data exist on the pathogenic mutations of LDL receptor in Japanese familial hypercholesterolemia (FH).
Objective: We aimed to catalog the pathogenic mutations of LDL receptor gene in the 2 major Japanese FH-care centers (Kanazawa University and National Cerebral and Cardiovascular Center Research Institute), where genetic testing of FH has been performed centrally on requests from institutes all over Japan during more than past 2 decades.
Methods: 796 FH subjects from 472 families who had nonsynonymous mutations in LDL receptor gene were included in this study. Genetic mutations were analyzed for mutations by Sanger sequencing as well as by multiplex ligation probe dependent amplification technique for large rearrangements. Pathogenic mutations were defined either as 1) protein truncated variants, 2) registered as pathogenic in ClinVar, or Human Gene Mutation Database (HGMD), or meet the criteria of American College of Medical Genetics and Genomics guideline, or 3) CADD score > 10.
Results: We found 138 different mutations. Among them, 132 mutations were considered as pathogenic, including 19 large rearrangement mutations. However, 6 missense mutations were classified as variants of unknown significance. A single mutation accounted for as much as 41% of the FH subjects recruited from Kanazawa University mainly due to founder gene effect, whereas many singleton mutations were found from National Cerebral and Cardiovascular Center Research Institute located in Osaka.
Conclusions: We provided the largest catalog of pathogenic mutations of LDL receptor gene in Japanese FH. This could aid to determine the pathogenicity of the LDL receptor genetic mutations not only in Japanese but also in other ethnicities.
Keywords: Familial hypercholesterolemia; Genetics; LDL cholesterol; LDL receptor.
Copyright © 2020 National Lipid Association. Published by Elsevier Inc. All rights reserved.
Similar articles
- The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.Dan Med Bull. 2002 Nov;49(4):318-45.PMID: 12553167 Review.
- Familial Hypercholesterolemia.2014 Jan 2 [updated 2016 Dec 8]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.PMID: 24404629 Free Books & Documents. Review.
- Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.Lipids Health Dis. 2018 May 2;17(1):100. doi: 10.1186/s12944-018-0763-z.PMID: 29720182 Free PMC article.
- Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.J Am Coll Cardiol. 2016 Jun 7;67(22):2578-89. doi: 10.1016/j.jacc.2016.03.520. Epub 2016 Apr 3.PMID: 27050191 Free PMC article.
- Low density lipoprotein--receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia.J Atheroscler Thromb. 2005;12(5):276-83. doi: 10.5551/jat.12.276.PMID: 16205024 Clinical Trial.
No hay comentarios:
Publicar un comentario